- Open Access
Association between genetic polymorphisms and carotid atherosclerosis in patients treated with radiotherapy for nasopharyngeal carcinoma
© Yuan et al.; licensee BioMed Central. 2015
- Received: 11 October 2014
- Accepted: 28 January 2015
- Published: 13 February 2015
Radiotherapy (RT) of the neck is commonly given to nasopharyngeal carcinoma (NPC) patients for preventing cervical lymph node metastasis. However, neck RT may induce the development of carotid atherosclerosis. The mechanisms of radiation-induced carotid atherosclerosis are still unclear and no previous study has investigated the genetic involvement of radiation-induced carotid atherosclerosis. The present study aims to determine the association between genetic polymorphisms and carotid atherosclerosis in patients treated with RT for nasopharyngeal carcinoma.
The present study recruited 128 post-RT NPC patients. Carotid plaque score was assessed using ultrasonography. Thirteen single nucleotide polymorphisms (SNPs) that affect the function of anti-atherosclerotic genes, including SOD2, SOD3, CAT, PON1, PPARG, ADIPOQ, IL10, TGFB1 and NOS3, were genotyped. Association between the 13 SNPs and carotid atherosclerosis was evaluated using multiple regression after adjustment for covariates (PLINK). Multiple testing was corrected using Benjamini-Hochberg step-up false discovery rate controlling procedure.
rs662 and rs705379 of PON1 were close to be significantly associated with carotid plaque score (Corrected P value, P cor = 0.0528 and P cor = 0.0842). When the two SNPs were combined together, TC haplotype in rs662-rs705379 of PON1 was significantly associated with higher carotid plaque score (P cor < 0.05). None of the other SNPs showed significant association with carotid plaque score.
TC haplotype in rs662-rs705379 of PON1 is likely to be a genetic risk factor of carotid plaque score. Post-RT NPC patients with the TC haplotype may need earlier and more frequent carotid ultrasound examinations for early detection of carotid atherosclerosis.
- Nasopharyngeal carcinoma
- Carotid atherosclerosis
- Carotid plaque score
- Single nucleotide polymorphisms
Nasopharyngeal carcinoma (NPC) is a common head and neck malignancy in Southeast Asia and Southern China . Radiotherapy (RT) is the standard strategy for treating nasopharyngeal carcinoma (NPC). Owing to the high prevalence of cervical lymph node metastasis in NPC patients, RT of the neck is usually given to the patients for preventing or treating the nodal metastasis . However, ionizing radiation in neck RT damages the carotid artery and may induce carotid atherosclerosis, which may lead to cerebrovascular events [3-6].
The mechanisms of radiation-induced carotid atherosclerosis are still unknown. However, the mechanisms of spontaneous atherosclerosis are well established, which provide baseline information for the understanding of the mechanisms of radiation-induced carotid atherosclerosis. Different pathways in the regulation of oxidative stress, lipid metabolisms, and inflammation may protect the carotid artery from atherosclerosis. There are many genes whose encoded proteins are involved in these protective pathways. Superoxide dismutases (SODs) are the primary enzymes in the defense of oxidative stress, which convert the toxic superoxide anions to the less toxic hydrogen peroxide (H2O2) . Catalase (CAT) further scavenges the toxic H2O2 by converting it into water (H2O) and molecular oxygen (O2) . Paraoxonase 1 (PON1) prevents the oxidation of low intensity lipoprotein (LDL), and inhibits the uptake of oxidized LDL by and cholesterol synthesis in macrophages . Peroxisome proliferators-activated receptor γ (PPARG) is a pivotal nuclear receptor that regulates the expression of genes involved in lipid metabolisms and inflammatory responses . Adiponectin (ADIPOQ) suppresses the inflammatory responses and the uptake of oxLDL by macrophages . Interleukin-10 (IL10) and transforming growth factor-β1 (TGFB1) are the most important anti-inflammatory cytokines in immune cells [12,13]. Endothelial nitric oxide synthase (NOS3) catalyzes the production of nitric oxide, which prevents platelet aggregation, adhesion molecule expression in endothelial cells and vascular SMC proliferation .
Some single nucleotide polymorphisms (SNPs) that affect the expression of these genes (SOD2, SOD3, CAT, PON1, PPARG, ADIPOQ, IL10, TGFB1 and NOS3) and/or the functions of their corresponding proteins have been shown to be associated with spontaneous atherosclerosis [15-24]. However, the association of these SNPs with radiation-induced carotid atherosclerosis is still unknown. Therefore, the present study was undertaken to investigate the association between the SNPs in these nine genes and the severity of carotid atherosclerosis in post-RT NPC patients. The findings will offer potential genetic markers of radiation-induced carotid atherosclerosis, which might facilitate the selection of high-risk patients with carotid atherosclerosis so that timely diagnosis and treatment can be given to the patients.
Post-RT NPC patients were recruited from the Department of Clinical Oncology of Queen Mary Hospital from March 2013 to March 2014. The inclusion criteria of subjects were local residents, Han Chinese NPC patients, older than 18 years, and completed RT for at least four years, whilst the exclusion criteria of subjects were more than one course of RT, history of carotid atherosclerosis prior to RT, previous carotid endarterectomy and carotid stenting.
This study was approved by the Human Subject Ethics Subcommittee of the Hong Kong Polytechnic University and the Institutional Review Board of the University of Hong Kong/Hospital Authority Hong Kong West Cluster. Written consent was obtained from all patients before the commencement of the interview and ultrasound examination.
Archived clinical records were reviewed and individual face-to-face interviews were conducted. The information of post-RT duration, radiation dose, chemotherapy and history of carotid atherosclerosis was obtained from archived clinical records. The presence of cardiovascular risk factors was identified as follows: 1) DM, diagnosed with DM in the clinical record, taking medications to lower blood glucose and/or fasting plasma (blood) glucose ≥ 7.0 (6.1) mmol/L ; 2) hypertension, diagnosed with hypertension in the clinical record, undergoing anti-hypertensive medications and/or the measured blood pressure ≥ 140/90 mmHg ; 3) hypercholesterolemia, diagnosed with hypercholesterolemia in the clinical record, undergoing medications to lower the cholesterol level and/or fasting total cholesterol ≥ 5.2 mmol/L ; 4) CHD, diagnosed with coronary vascular disease in the clinical record and/or had coronary stenting ; 5) smoking, current smoker consuming 10 cigarettes per day for at least six months .
Selecting and genotyping of SNPs
Primers and probes in genotyping
CCA GCC TGC GTA GAC GGT
CGT GGT GCT TGC TGT GGT G
AGC CCA GAT ACC CCA AAG CCG GAG CCA Gaa
AGG ACT CAG CGG AGC CCA ACT
18 T + TTG GCA CGG GAC GCA AGC TG
TGT TAC CGC CCC TAG TCA GTG TC
CAC CTC GGG AGC ACC TTT ACC A
10 T + GAA TGA TAT TGT TGC TGT GGG ACC TGA G
CCA TCG GGT GAA CTG TTG ATT CCA TTA G
AAA TGG GAC TTT TGG CTG A
ACA CTG ACG GGC TAG GA
CGC CGA TTT GCC CGC CCC GCC CCT CCC Caa ta
GCT GAA CCA TCC TGA GTC CTC
33 T + TGG AAG AAG GGA CAT GTT GGC
CAC CGA CAG AGC CTT GCA CAT TAG
GGG GGT CTG CAC AGG TTG GAT G
15 T + GAT GCT GTT GCT GGG AGC TGT
30 T + CCC GAG A CGC CAT CCA ACC TGT GC
GGA GCC TGG AAC ACA TCC TG
AAA TGA GGG GGT GGG CTA AAT ATC
ACC CCC CCT GTC CTG TAG GAA GCC AGt CTa ata
TGA CCC CAG CTA AGG CAT G
TTT TTC CTC TTC TCC CGA CCA G
TCA CCA GCT CCA TGT CGA TA
ATC CCT GTT CGC GCT CTC
CAG CAG CGG TAG CAG CAG CGG CAG CAG Caa
TCA CTG CAA CCT CTG TGT CTT
20 T + CTG CAT ATT TGA CAC CCT GTA TT
ACC CCA GAA AAC GGT CGC TTC G
CCC CGA TTT CCA GCA GCA TGT TG
Data of carotid plaque score was transformed logarithmically because it was not normally distributed. Testing of genotypes for Hardy-Weinberg equilibrium (HWE) in all subjects was determined by exact test as executed in PLINK (version 1.07, ). The threshold for significant deviation from HWE was set as 0.01 . Only markers fulfilling HWE were included in association analyses.
In the potential covariates, such as age, gender, radiation dose, chemotherapy, post-RT duration and cardiovascular risk factors, the significant predictors in regression models were adjusted in association analyses. Linear regression executed in PLINK was used for assessing the association between single SNP and carotid plaque score with adjustment for post-RT duration and number of cardiovascular risk factors (significant predictors in regression models). The regression analysis was performed under additive, dominant or recessive models. FDR correction was used for correcting multiple testing. P cor < 0.05 was considered as significant for association analysis.
Three genes, PON1, ADIPOQ and TGFB1, had more than one SNP examined in the present study. The haplotypes in each of these three genes were determined for the association with carotid plaque score in post-RT NPC patients. Sliding window (2 or 3 SNPs per window) using linear regression in PLINK was utilized for the association analysis with adjustment for post-RT duration and number of cardiovascular risk factors. FDR correction was also used for correcting multiple testing. Linkage disequilibrium (LD) statistics D’ and r2 in paired SNPs were calculated using Pairwise LD in PLINK. P cor < 0.05 was considered as significant for association analysis.
Demographic information of post-RT NPC patients
Total n = 128
55.2 ± 8.8
Gender (female/male), n
Chemotherapy, n (%)
Radiation dose, Gy
66.82 ± 3.20
Post-RT duration, years
12.6 ± 6.0
Hypercholesterolemia, n (%)
Hypertension, n (%)
Diabetes mellitus, n (%)
Current smoker, n (%)
Coronary heart disease, n (%)
Stroke or transient ischemia attack, n (%)
Presence of carotid plaque, n (%)
Carotid plaque score
1.41 ± 1.37
Genotypes, minor allele frequency, Hardy-Weinberg Equilibrium and single-marker association analysis in all selected SNPs
Alleles a (1/2)
Corrected P values b
Association analyses between haplotypes and carotid plaque score in post-RT NPC patients
Carotid atherosclerosis is a common complication in post-RT NPC patients. However, the mechanisms of radiation-induced carotid atherosclerosis are still unclear and no previous study has reported the association between genetic polymorphisms and radiation-induced carotid atherosclerosis. The present study comprehensively investigated the association between 13 SNPs in anti-atherosclerotic genes and radiation-induced carotid atherosclerosis. Results showed that SNPs in PON1 tended to be genetically associated with carotid plaque score in post-RT NPC patients.
PON1 is one of the important enzymes for hydrolyzing LDL oxidation, playing a pivotal role against carotid atherosclerosis. The SNP rs662 (T > C) locating in the coding region of PON1 gene replaces glutamine (Q) by arginine (R) at codon 192 (Q192R). This variation affects the activities of PON1 in the hydrolysis of different substrates. The 192Q allozyme has higher hydrolytic activity toward diazoxon, soman and sarin, while the 192R allozyme is more efficient for hydrolyzing paraoxon and fenitroxon [35,36]. Another important variation, rs705379, is located at position −107 of the promoter region (−107 T/C), which contributes to a decrease in the PON1 expression level and PON1 circulating concentration .
In the present study, significant observed P values were found in the association analyses between carotid plaque score and rs662 as well as rs705379 in additive and dominant models (rs662, P = 0.0054 and 0.0014 respectively; rs705379, P = 0.0077 and 0.0086 respectively). The significant association failed to survive in the correction for multiple testing by FDR, but it was close to be significant (P cor = 0.0528 and 0.0842 respectively). In the association analyses with rs662 and rs705379, the statistical power was 0.524 and 0.302 respectively. To achieve a statistical power of 0.8, at least 194 and 283 patients would be needed respectively. Therefore, small sample size in the present study (n = 128) may account for the non-significant findings. Future studies with larger sample sizes are needed for investigating the association. Nevertheless, the two SNPs had a cumulative effect on carotid plaque score. Patients carrying T allele in rs662 (QR + QQ, n = 64) had 1.76 ± 1.60 of carotid plaque score, whilst those with CC genotype in rs705379 (n = 44) had 1.79 ± 1.82 of carotid plaque score. In patients carrying both T allele in rs662 and CC genotype in rs705379 (n = 38), the plaque score was 1.94 ± 1.89. TC haplotype in rs662-rs705379 showed significant association with the plaque score after the correction for multiple testing (P cor = 0.0158). Thus, rs662 and rs70539 in combination were more powerful to detect the association with carotid plaque score in the present study. TC in rs662-rs705379 would be the risk haplotype for carotid plaque score in post-RT NPC patients.
D’ and r2 of the two SNPs were 0.871 and 0.294 respectively. The high D’ indicated that the two SNPs were in LD and were co-inherited most of the time. However, the different frequencies of alleles in the two SNPs (minor allele frequency = 0.3086 and 0.4648 respectively) resulted in the low r2. Therefore, the two SNPs cannot predict for each other.
In contrast to previous studies in which the R variant of the Q192R polymorphism (C allele in rs662) was a risk factor for spontaneous atherosclerosis diseases [21,38], the present study found that the R variant would be protective for radiation-induced carotid atherosclerosis. Patients carrying RR had lower plaque score as compared to those with QR and QQ genotypes (RR vs QR + QQ: 1.07 ± 0.97 vs 1.76 ± 1.60). In an in vitro model, Aviram et al. documented that RR and QQ allozymes serve anti-oxidant activities in different stages based on different substrates . The various hydrolytic activities of R and Q allozymes in PON1 for different substrates may account for the conflicting results between the present and previous studies. The oxidative condition in the irradiated cases may be different from that in those without radiation treatment. PON1 may protect LDL from oxidation by a certain activity based on the different substrates in the irradiated cases and the non-irradiated ones. Thus, RR of Q192R polymorphism would be protective against radiation-induced carotid atherosclerosis, although it may be the risk of spontaneous atherosclerosis diseases.
The present study was a cross-sectional investigation with only 128 post-RT NPC patients and without a non-irradiated control group. The study design and small sample size limited the statistical power in association analyses. Thus, the potential association between some SNPs and carotid plaque score in post-RT NPC patients, and the potential interaction between the TC haplotype and irradiation, may not be fully investigated. In addition, the present study did not investigate the PON1 concentration and activity due to limited resources. Whether the TC haplotype decreases the concentration and activity of PON1 and consequently promotes the plaque score in post-RT NPC patients remains to be confirmed in future studies. Given that this study was an exploratory investigation, and the sample size and study design were limited, future investigations, especially prospective studies, are suggested to investigate the role of PON1 in the development of radiation-induced carotid atherosclerosis and the effectiveness of using the TC haplotype in the prevention of radiation-induced carotid atherosclerosis.
TC haplotype in rs662-rs705379 of PON1 is likely to be a genetic risk factor of carotid plaque score. The present study provides preliminary finding of the association between genetic polymorphisms with the radiation-induced carotid atherosclerosis in post-RT NPC patients, which facilitates the understanding of genetic markers for the selection of NPC patients with high risk of carotid atherosclerosis so as to conduct appropriate examinations for early diagnosis and prompt treatment for carotid atherosclerosis in post-RT NPC patients.
We thank the staff in the Department of Clinical Oncology of Queen Mary Hospital for their assistance in the study. This study was supported by a research studentship from the Hong Kong Polytechnic University (RU2R).
- Chang ET, Adami HO. The enigmatic epidemiology of nasopharyngeal carcinoma. Cancer Epidemiol Biomark Prev. 2006;15:1765–77.View ArticleGoogle Scholar
- Lu H, Yao M. The current status of intensity-modulated radiation therapy in the treatment of nasopharyngeal carcinoma. Cancer Treat Rev. 2008;34:27–36.View ArticlePubMedGoogle Scholar
- Muzaffar K, Collins SL, Labropoulos N, Baker WH. A prospective study of the effects of irradiation on the carotid artery. Laryngoscope. 2000;110:1811–4.View ArticlePubMedGoogle Scholar
- Lam WW, Leung SF, So NM, Wong KS, Liu KH, Ku PK, et al. Incidence of carotid stenosis in nasopharyngeal carcinoma patients after radiotherapy. Cancer. 2001;92:2357–63.View ArticlePubMedGoogle Scholar
- Lam WW, Yuen HY, Wong KS, Leung SF, Liu KH, Metreweli C. Clinically underdetected asymptomatic and symptomatic carotid stenosis as a late complication of radiotherapy in Chinese nasopharyngeal carcinoma patients. Head Neck. 2001;23:780–4.View ArticlePubMedGoogle Scholar
- Li CS, Schminke U, Tan TY. Extracranial carotid artery disease in nasopharyngeal carcinoma patients with post-irradiation ischemic stroke. Clin Neurol Neurosurg. 2010;112:682–6.View ArticlePubMedGoogle Scholar
- Zelko IN, Mariani TJ, Folz RJ. Superoxide dismutase multigene family: A comparison of the CuZn-SOD (SOD1), Mn-SOD (SOD2), and EC-SOD (SOD3) gene structures, evolution, and expression. Free Radic Biol Med. 2002;33:337–49.View ArticlePubMedGoogle Scholar
- He SQ, Zhang YH, Venugopal SK, Dicus CW, Perez RV, Ramsamooj R, et al. Delivery of antioxidative enzyme genes protects against ischemia/reperfusion-induced liver injury in mice. Liver Transpl. 2006;12:1869–79.View ArticlePubMedGoogle Scholar
- Aviram M, Rosenblat M. Paraoxonases 1, 2, and 3, oxidative stress, and macrophage foam cell formation during atherosclerosis development. Free Radic Biol Med. 2004;37:1304–16.View ArticlePubMedGoogle Scholar
- Li AC, Binder CJ, Gutierrez A, Brown KK, Plotkin CR, Pattison JW, et al. Differential inhibition of macrophage foam-cell formation and atherosclerosis in mice by PPARalpha, beta/delta, and gamma. J Clin Invest. 2004;114:1564–76.View ArticlePubMed CentralPubMedGoogle Scholar
- Wolf AM, Wolf D, Rumpold H, Enrich B, Tilg H. Adiponectin induces the anti-inflammatory cytokines IL-10 and IL-1RA in human leukocytes. Biochem Biophys Res Commun. 2004;323:630–5.View ArticlePubMedGoogle Scholar
- Wakkach A, Cottrez F, Groux H. Can interleukin-10 be used as a true immunoregulatory cytokine? Eur Cytokine Netw. 2000;11:153–60.PubMedGoogle Scholar
- Wahl SM, Wen J, Moutsopoulos N. TGF-beta: a mobile purveyor of immune privilege. Immunol Rev. 2006;213:213–27.View ArticlePubMedGoogle Scholar
- Napoli C, Ignarro LJ. Polymorphisms in endothelial nitric oxide synthase and carotid artery atherosclerosis. J Clin Pathol. 2007;60:341–4.View ArticlePubMed CentralPubMedGoogle Scholar
- Kakko S, Paivansalo M, Koistinen P, Kesaniemi YA, Kinnula VL, Savolainen MJ. The signal sequence polymorphism of the MnSOD gene is associated with the degree of carotid atherosclerosis. Atherosclerosis. 2003;168:147–52.View ArticlePubMedGoogle Scholar
- Casas JP, Bautista LE, Humphries SE, Hingorani AD. Endothelial nitric oxide synthase genotype and ischemic heart disease - Meta-analysis of 26 studies involving 23028 subjects. Circulation. 2004;109:1359–65.View ArticlePubMedGoogle Scholar
- Fujimoto H, Taguchi JI, Imai Y, Ayabe S, Hashimoto H, Kobayashi H, et al. Manganese superoxide dismutase polymorphism affects the oxidized low-density lipoprotein-induced apoptosis of macrophages and coronary artery disease. Eur Heart J. 2008;29:1267–74.View ArticlePubMedGoogle Scholar
- Naganuma T, Nakayama T, Sato N, Fu Z, Soma M, Aoi N, et al. Association of extracellular superoxide dismutase gene with cerebral infarction in women: a haplotype-based case–control study. Hereditas. 2008;145:283–92.View ArticlePubMedGoogle Scholar
- Deng HB, Jiang CQ, Tomlinson B, Liu B, Lin JM, Wong KS, et al. A polymorphism in transforming growth factor-beta1 is associated with carotid plaques and increased carotid intima-media thickness in older Chinese men: the Guangzhou Biobank Cohort Study-Cardiovascular Disease Subcohort. Atherosclerosis. 2010;214:391–6.View ArticlePubMedGoogle Scholar
- Dutkiewicz G, Domanski L, Binczak-Kuleta A, Pawlik A, Safranow K, Ciechanowicz A, et al. The association of -262C/T polymorphism in the catalase gene and delayed graft function of kidney allografts. Nephrology (Carlton). 2010;15:587–91.View ArticleGoogle Scholar
- Wang MS, Lang XL, Zou LJ, Huang SD, Xu ZY. Four genetic polymorphisms of paraoxonase gene and risk of coronary heart disease: A meta-analysis based on 88 case–control studies. Atherosclerosis. 2011;214:377–85.View ArticlePubMedGoogle Scholar
- Morris DR, Moxon JV, Biros E, Krishna SM, Golledge J. Meta-Analysis of the Association between Transforming Growth Factor-Beta Polymorphisms and Complications of Coronary Heart Disease. Plos One. 2012;7:e37878.View ArticlePubMed CentralPubMedGoogle Scholar
- Zhang H, Mo XB, Hao YC, Gu DF. Association between polymorphisms in the adiponectin gene and cardiovascular disease: a meta-analysis. BMC Med Genet. 2012;13:40.View ArticlePubMed CentralPubMedGoogle Scholar
- Wu ZJ, Lou YQ, Jin W, Liu Y, Lu L, Lu GP. The C161T polymorphism in the peroxisome proliferator-activated receptor gamma gene (PPAR gamma) is associated with risk of coronary artery disease: a meta-analysis. Mol Biol Rep. 2013;40:3101–12.View ArticlePubMedGoogle Scholar
- Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med. 1998;15:539–53.View ArticlePubMedGoogle Scholar
- Carretero OA, Oparil S. Essential hypertension Part I: definition and etiology. Circulation. 2000;101:329–35.View ArticlePubMedGoogle Scholar
- Ford ES, Li CY, Pearson WS, Zhao GX, Mokdad AH. Trends in hypercholesterolemia, treatment and control among United States adults. Int J Cardiol. 2010;140:226–35.View ArticlePubMedGoogle Scholar
- Chang YJ, Chang TC, Lee TH, Ryu SJ. Predictors of carotid artery stenosis after radiotherapy for head and neck cancers. J Vasc Surg. 2009;50:280–5.View ArticlePubMedGoogle Scholar
- Jiang B, Yap MK, Leung KH, Ng PW, Fung WY, Lam WW, et al. PAX6 haplotypes are associated with high myopia in Han chinese. Plos One. 2011;6:e19587.View ArticlePubMed CentralPubMedGoogle Scholar
- Mak JY, Yap MK, Fung WY, Ng PW, Yip SP. Association of IGF1 gene haplotypes with high myopia in Chinese adults. Arch Ophthalmol. 2012;130:209–16.View ArticlePubMedGoogle Scholar
- Yiu WC, Yap MK, Fung WY, Ng PW, Yip SP. Genetic susceptibility to refractive error: association of vasoactive intestinal peptide receptor 2 (VIPR2) with high myopia in Chinese. Plos One. 2013;8:e61805.View ArticlePubMed CentralPubMedGoogle Scholar
- Matthews KA, Kuller LH, Sutton-Tyrrell K, Chang YF. Changes in cardiovascular risk factors during the perimenopause and postmenopause and carotid artery atherosclerosis in healthy women. Stroke. 2001;32:1104–11.View ArticlePubMedGoogle Scholar
- Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MAR, Bender D, et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet. 2007;81:559–75.View ArticlePubMed CentralPubMedGoogle Scholar
- Wigginton JE, Cutler DJ, Abecasis GR. A note on exact tests of Hardy-Weinberg equilibrium. Am J Hum Genet. 2005;76:887–93.View ArticlePubMed CentralPubMedGoogle Scholar
- Richter RJ, Jampsa RL, Jarvik GP, Costa LG, Furlong CE. Determination of paraoxonase 1 status and genotypes at specific polymorphic sites. Curr Protoc toxicol. 2004;UNIT 4:12.Google Scholar
- Ginsberg G, Neafsey P, Hattis D, Guyton KZ, Johns DO, Sonawane B. Genetic Polymorphism in Paraoxonase 1 (Pon1): Population Distribution of Pon1 Activity. J Toxicol Environ Health B Crit Rev. 2009;12:473–507.View ArticlePubMedGoogle Scholar
- Brophy VH, Jampsa RL, Clendenning JB, McKinstry LA, Jarvik GP, Furlong CE. Effects of 5′ regulatory-region polymorphisms on paraoxonase-gene (PON1) expression. Am J Hum Genet. 2001;68:1428–36.View ArticlePubMed CentralPubMedGoogle Scholar
- Wheeler JG, Keavney BD, Watkins H, Collins R, Danesh J. Four paraoxonase gene polymorphisms in 11,212 cases of coronary heart disease and 12,786 controls: meta-analysis of 43 studies. Lancet. 2004;363:689–95.View ArticlePubMedGoogle Scholar
- Aviram M, Billecke S, Sorenson R, Bisgaier C, Newton R, Rosenblat M, et al. Paraoxonase active site required for protection against LDL oxidation involves its free sulfhydryl group and is different from that required for its arylesterase/paraoxonase activities: selective action of human paraoxonase allozymes Q and R. Arterioscler Thromb Vasc Biol. 1998;18:1617–24.View ArticlePubMedGoogle Scholar
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.